Reduced Mycobacterium tuberculosis association with monocytes from diabetes patients that have poor glucose control

Tuberculosis

Volumn 93, Issue 2, 2013, Pages 192-197

  Gomez, Diana I ^a   Twahirwa, Marcel ^b   Schlesinger, Larry S ^c   Restrepo, Blanca I ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b Doctors Hospital at Renaissance   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Complement; Diabetes; Monocyte; Mycobacterium; Tuberculosis

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; PHAGOCYTOSIS; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; COMPLEMENT SYSTEM PROTEINS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; OPSONIN PROTEINS; PHAGOCYTOSIS; SEX FACTORS; SIGNAL TRANSDUCTION; TUBERCULOSIS;

EID: 84875229012     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2012.10.003     Document Type: Article

References (39)

1. World Health Organization Tuberculosis global facts 2011/2012 2011 Available at: http://www.who.int/tb/publications/2011/factsheet-tb-2011.pdf
2. International Diabetes Federation Diabetes atlas 2009 Available at: http://www.diabetesatlas.org/
3. B. Restrepo, A. Camerlin, M. Rahbar, M. Restrepo, I. Zarate, and R. Wing Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis patients Bull World Health Organ 89 2011 352 359
4. C.Y. Jeon, and M.B. Murray Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies PLoS Med 5 2008 1091 1101
5. American Thoracic Society, Infectious Diseases Society of America, Centers for Disease Control and Prevention. Controlling tuberculosis in the United States Am J Respir Crit Care Med 172 2005 1169 1227
6. J.E. Stalenhoef, B. Alisjahbana, E.J. Nelwan, V. van d, T.H. Ottenhoff, and J.W. van der Meer The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus Eur J Clin Microbiol Infect Dis 27 2008 97 103
7. I. Gonzalez-Curiel, J. Castaneda-Delgado, N. Lopez-Lopez, Z. Araujo, R. Hernandez-Pando, and B. Gandara-Jasso Differential expression of antimicrobial peptides in active and latent tuberculosis and its relationship with diabetes mellitus Hum Immunol 72 2011 656 662
8. G.W. Martens, M.C. Arikan, J. Lee, F. Ren, D. Greiner, and H. Kornfeld Tuberculosis susceptibility of diabetic mice Am J Respir Cell Mol Biol 37 2007 518 524
9. T. Vallerskog, G.W. Martens, and H. Kornfeld Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis J Immunol 184 2010 6275 6282
10. T. Komura, Y. Sakai, M. Honda, T. Takamura, K. Matsushima, and S. Kaneko CD14+ monocytes are vulnerable and functionally impaired under endoplasmic reticulum stress in patients with type 2 diabetes Diabetes 59 2010 634 643
11. Y. Ding, A. Kantarci, H. Hasturk, P.C. Trackman, A. Malabanan, and T.E. Van Dyke Activation of RAGE induces elevated O2-generation by mononuclear phagocytes in diabetes J Leukoc Biol 81 2007 520 527
12. K.S. Tan, K.O. Lee, K.C. Low, A.M. Gamage, Y. Liu, and G.Y. Tan Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria J Clin Invest 122 2012 2289 2300
13. E.J. Glass, J. Stewart, D.M. Matthews, A. Collier, B.F. Clarke, and D.M. Weir Impairment of monocyte "lectin-like" receptor activity in type 1 (insulin-dependent) diabetic patients Diabetologia 30 1987 228 231
14. H.R. Hill, N.H. Augustine, M.L. Rallison, and J.I. Santos Defective monocyte chemotactic responses in diabetes mellitus J Clin Immunol 3 1983 70 77
15. S. Katz, B. Klein, I. Elian, P. Fishman, and M. Djaldetti Phagocytotic activity of monocytes from diabetic patients Diabetes Care 6 1983 479 482
16. F.Y. Chang, and M.F. Shaio Decreased cell-mediated immunity in patients with non-insulin-dependent diabetes mellitus Diabetes Res Clin Pract 28 1995 137 146
17. C.E. Mathews, E.L. Brown, P.J. Martinez, U. Bagaria, M. Nahm, and R.L. Burton Impaired function of antibodies to pneumococcal surface protein A and not to capsular polysaccharide in Mexican American adults with type 2 diabetes mellitus Clin Vaccine Immunol 19 2012 1360 1369
18. M. Noritake, Y. Katsura, N. Shinomiya, M. Kanatani, Y. Uwabe, and N. Nagata Intracellular hydrogen peroxide production by peripheral phagocytes from diabetic patients. Dissociation between polymorphonuclear leucocytes and monocytes Clin Exp Immunol 88 1992 269 274
19. L.S. Schlesinger Entry of Mycobacterium tuberculosis into mononuclear phagocytes Curr Top Microbiol Immunol 215 1996 71 96
20. L.S. Schlesinger Mycobacterium tuberculosis and the complement system Trends Microbiol 6 1998 47 49
21. L.S. Schlesinger, C.G. Bellinger-Kawahara, N.R. Payne, and M.A. Horwitz Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3 J Immunol 144 1990 2771 2780
22. E.J. Bardana Jr., J.K. McClatchy, R.S. Farr, and P. Minden Universal occurrence of antibodies to tubercle bacilli in sera from non-tuberculous and tuberculous individuals Clin Exp Immunol 13 1973 65 77
23. C. Geisler, T. Almdal, J. Bennedsen, J.M. Rhodes, and K. Kolendorf Monocyte functions in diabetes mellitus Acta Pathol Microbiol Immunol Scand C 90 1982 33 37
24. American Diabetes Association Standards of medical care in diabetes-2010 Diabetes Care 33 2010 S11 S61
25. L.S. Schlesinger Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors J Immunol 150 1993 2920 2930
26. M. Zhang, J. Gong, Y. Lin, and P.F. Barnes Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages Infect Immun 66 1998 794 799
27. J.S. Ferguson, J.J. Weis, J.L. Martin, and L.S. Schlesinger Complement protein C3 binding to Mycobacterium tuberculosis is initiated by the classical pathway in human bronchoalveolar lavage fluid Infect Immun 72 2004 2564 2573
28. J.D. Ernst Macrophage receptors for Mycobacterium tuberculosis Infect Immun 66 1998 1277 1281
29. T. Marth, and B.L. Kelsall Regulation of interleukin-12 by complement receptor 3 signaling J Exp Med 185 1997 1987 1995
30. F.S. Sutterwala, G.J. Noel, R. Clynes, and D.M. Mosser Selective suppression of interleukin-12 induction after macrophage receptor ligation J Exp Med 185 1997 1977 1985
31. H.J. Muller-Eberhard Molecular organization and function of the complement system Annu Rev Biochem 57 1988 321 347
32. D.E. Goldstein, R.R. Little, R.A. Lorenz, J.I. Malone, D.M. Nathan, and C.M. Peterson Tests of glycemia in diabetes Diabetes Care 27 Suppl. 1 2004 S91 S93
33. M. Arai, M. Uchiba, H. Komura, Y. Mizuochi, N. Harada, and K. Okajima Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro J Pharmacol Exp Ther 334 2010 206 213
34. K. Labuzek, S. Liber, B. Gabryel, J. Adamczyk, and B. Okopien Metformin increases phagocytosis and acidifies lysosomal/endosomal compartments in AMPK-dependent manner in rat primary microglia Naunyn Schmiedebergs Arch Pharmacol 381 2010 171 186
35. E.L. Pearce, M.C. Walsh, P.J. Cejas, G.M. Harms, H. Shen, and L.S. Wang Enhancing CD8 T-cell memory by modulating fatty acid metabolism Nature 460 2009 103 107
36. J.D. Bagdade, K.L. Nielson, and R.J. Bulger Reversible abnormalities in phagocytic function in poorly controlled diabetic patients Am J Med Sci 263 1972 451 456
37. E.J. Rayfield, M.J. Ault, G.T. Keusch, M.J. Brothers, C. Nechemias, and H. Smith Infection and diabetes: the case for glucose control Am J Med 72 1982 439 450
38. N.J. Davidson, J.M. Sowden, and J. Fletcher Defective phagocytosis in insulin controlled diabetics: evidence for a reaction between glucose and opsonising proteins J Clin Pathol 37 1984 783 786
39. P.S. Hair, C.G. Echague, R.D. Rohn, N.K. Krishna, J.O. Nyalwidhe, and K.M. Cunnion Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus J Transl Med 10 2012 35